Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension
Status:
Completed
Trial end date:
2017-12-25
Target enrollment:
Participant gender:
Summary
This is a randomized study with two treatment arms: 'initial Selective Laser Trabeculoplasty
(SLT) followed by conventional medical therapy as required' ('Laser-1st') and 'medical
therapy without laser ('Medicine-1st'). It compares quality of life in the two arms at three
years, while also examining the incremental cost and cost-effectiveness of Laser-1st versus
Medicine-1st.